Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CAR-T design: Elements and their synergistic function

EBioMedicine(2020)10.1016/j.ebiom.2020.102931Source: DataRank Database

CAR-T design: Elements and their synergistic function is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 0. It has been cited 358 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access358 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 10.60)OA: goldTopics (79)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Michael Mellody ORCID,Andrew J. Hou ORCID,Ruchi P. Desai,Audrey Fung ORCID,An Huynh Thuy Pham

Live enrichment

PubMed:32739874 OpenAlex:https://openalex.org/W3046025665

Mark Foundation For Cancer Research

Grant: US2019/036,731

Mark Foundation For Cancer Research

Grant: US62/091,854

National Institutes of Health

Grant: R21CA219225

National Science Foundation

Grant: DGE-1,839,285

National Science Foundation

Grant: 1,913,404

Congressionally Directed Medical Research Programs

Grant: W81XWH-17\u20131\u20130522

Congressionally Directed Medical Research Programs

Grant: W81XWH-17

Congressionally Directed Medical Research Programs

Grant: AR3T P2CHD086843

National Institutes of Health

Grant: 5P2CHD086843-07

Alliance for Regenerative Rehabilitation Research & Training 2.0 (AR3T 2.0)

National Institutes of Health

Grant: 1R21CA219225-01

Mechano-Sensing CAR-T Cells for Solid Tumor Metastases

NICHD NIH HHS

Grant: P2C HD086843

NCI NIH HHS

Grant: P50 CA211015

FWCI

10.60

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttp://www.thelancet.com/article/S2352396420303078/pdf

publisherhttp://www.thelancet.com/article/S2352396420303078/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396420303078?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396420303078?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ebiom.2020.102931

Fields of Study

CAR-T cell therapy researchAdvancements in Semiconductor Devices and Circuit Design0301 basic medicine0303 health sciences03 medical and health sciencesAntigens, CD19B-LymphocytesHumansImmunotherapy, AdoptiveNeoplasmsReceptors, Chimeric Antigen

MeSH Terms

Receptors, Chimeric AntigenB-LymphocytesHumansNeoplasmsImmunotherapy, AdoptiveAntigens, CD19

Keywords

Function (biology)Computational biologyMedicineBiologyGeneticsMedicine (General)1117 Public Health and Health Services (for)EpidemiologyAdoptiveReviewImmunotherapy, AdoptiveAdoptive (mesh)NeoplasmsReceptors1103 Clinical Sciences (for)Chimeric antigen receptorImmunization (rcdc)32 Biomedical and Clinical Sciences (for-2020)CancerCancer (rcdc)Humans (mesh)Neoplasms (mesh)B-LymphocytesReceptors, Chimeric AntigenCD19RGene TherapyCAR-T5.1 PharmaceuticalsVaccine Related (rcdc)Public Health and Health ServicesChimeric Antigen (mesh)ImmunotherapyBiotechnologyOncology and CarcinogenesisImmunologyClinical SciencesAntigens, CD19610CD19 (mesh)Biotechnology (rcdc)Vaccine RelatedR5-9205.1 Pharmaceuticals (hrcs-rac)HumansAntigens3204 Immunology (for-2020)Synthetic biologyBiomedical and Clinical Sciences5.2 Cellular and gene therapiesGenetics (rcdc)B-Lymphocytes (mesh)Cell engineeringChimeric AntigenImmunotherapy (rcdc)5.2 Cellular and gene therapies (hrcs-rac)Cancer (hrcs-hc)3202 Clinical sciences (for-2020)Gene Therapy (rcdc)3211 Oncology and Carcinogenesis (for-2020)4202 Epidemiology (for-2020)Immunization

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Strategies to enhance CAR-T persistence

10.6084/m9.figshare.21622536.v1figshare

Additional file 1 of Strategies to enhance CAR-T persistence

10.6084/m9.figshare.21622536figshare